文献速递关节外科小儿骨科

儿童全髋关节置换术:荷兰关节置换登记研究283髋数据

Total Hip Arthroplasty in Children: A Dutch Arthroplasty Register Study with Data from 283 Hips.
PubMed 文献 · J Bone Joint Surg Am · 2025-02-13

该研究基于荷兰关节置换登记系统(LROI)2007至2022年数据,纳入283例11至18岁非肿瘤适应症初次全髋关节置换术(THA)髋,中位随访7年,5年和10年假体生存率分别为95%和91%,患者报告结局指标(PROMs)在术后12个月较术前显著改善。作者认为THA对于严重儿童髋部疾病是有效且令人满意的干预,需进一步研究长期生存率和假体失败危险因素。

要点

  • 儿童THA最常见的适应症为骨坏死(90髋,32%)、发育不良(82髋,29%)和骨关节炎(54髋,19%)。
  • 5年和10年累积假体生存率分别为95%(95%CI 91%至97%)和91%(95%CI 84%至95%)。
  • 所有PROMs在术后12个月较术前显著改善(p < 0.001)。

核心结论

  • 这是迄今规模最大的儿童(≤18岁)THA研究,显示良好的短期和中期假体生存率,接近成人水平。
  • 结合积极的PROM结果,THA似乎对严重儿童髋部疾病是有效且令人满意的干预。
  • 需进一步研究应关注长期生存率和假体失败的危险因素。

研究设计与样本

  • 研究从荷兰关节置换登记系统(LROI)提取2007年至2022年11至18岁非肿瘤适应症初次THA数据。
  • 纳入283髋(253例患者),其中女性患者161髋(57%),手术时平均年龄16±1.6岁。
  • 使用Kaplan-Meier生存分析评估假体生存率,PROMs在术前及术后3个月和12个月用配对t检验比较。

主要发现

  • 中位随访7年(范围2至16年),14髋(234髋中的6%)接受了翻修。
  • 5年和10年累积生存率分别为95%(95%CI 91%至97%)和91%(95%CI 84%至95%)。
  • 翻修潜在危险因素的事件数不足,无法进行统计分析。
  • 所有PROMs在术后12个月较术前显著改善(p < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 翻修潜在危险因素的事件数不足,无法进行统计分析。
  • 需进一步研究应关注长期生存率和假体失败的危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total hip arthroplasty (THA) is rarely performed in pediatric patients and can be challenging in children because of smaller-sized joints, pathomorphological changes around the hip, residual growth, and higher physical demands. Literature on THA outcomes in this unique population is scarce. We aimed to describe characteristics of pediatric patients who underwent THA, 5- and 10-year implant survival, risk factors for revision, and results of patient-reported outcome measures (PROMs) in a large national cohort. METHODS: Primary THAs (from 2007 through 2022) in pediatric patients (11 to 18 years of age) for non-oncological indications were extracted from the Dutch Arthroplasty Register (LROI). Implant survival was assessed using Kaplan-Meier survival analyses. Functional, quality-of-life, and pain-related PROM scores were described preoperatively and at 3 and 12 months postoperatively and compared using paired t tests. RESULTS: We included 283 THAs (161 [57%] in female patients) performed in 253 patients. The mean age at surgery (and standard deviation) was 16 ± 1.6 years. The most common indications were osteonecrosis (90 [32%] of the THA procedures), dysplasia (82 [29%]), and osteoarthritis (54 [19%]). The median follow-up was 7 years (range, 2 to 16 years). Fourteen (6% of 234) THAs were revised. The 5- and 10-year cumulative survival rates were 95% (95% confidence interval [CI], 91% to 97%) and 91% (95% CI, 84% to 95%), respectively. There was an insufficient number of events to allow for statistical analyses of potential risk factors for revision. All PROMs had improved significantly at 12 months postoperatively versus preoperatively (p < 0.001). CONCLUSIONS: This study, the largest to date on THA in children (≤18 years of age), showed good short- and mid-term THA survival, approaching that among adults. Combined with the positive PROM results, THA appears to be an effective and satisfactory intervention in cases of debilitating pediatric hip disease. Further studies should focus on long-term survival and risk factors for implant failure. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. van Kouswijk HW, Bus MPA, Gademan MGJ, et al. Total Hip Arthroplasty in Children: A Dutch Arthroplasty Register Study with Data from 283 Hips. J Bone Joint Surg Am. 2025. PMID: 39946439. doi:10.2106/JBJS.24.00657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。